An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study

Takuro Mizukami, Tempei Miyaji, Yukiya Narita, Tomohiro Matsushima, Takashi Ogura, Hiromichi Miyagaki, Ryohei Kawabata, Yoshiki Horie, Takashi Kawaguchi, Kei Muro, Hiroki Hara, Takuhiro Yamaguchi, Takako E Nakajima

研究成果: Article査読

抄録

Limited data are available regarding the efficacy of nutrition support in advanced gastric cancer (AGC) patients receiving a standard second-line combination chemotherapy. The BALAST study is conducted as a prospective, multicenter observational study to evaluate the efficacy of nutrition support for patients with AGC treated with ramucirumab plus taxane as second-line treatment. As part of the routine care, patients who are malnourished or at risk of malnutrition will receive nutrition support from dietitians. We will enroll a total of 26 patients to estimate weight control rate at 12 weeks as primary end point. This study will generate valuable data reinforcing the role of nutrition support therapy for AGC patients receiving second-line chemotherapy.

本文言語English
ページ(範囲)2431-2438
ページ数8
ジャーナルFuture Oncology
17
19
DOI
出版ステータスPublished - 2021 7

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「An observational study on nutrition status in gastric cancer patients receiving ramucirumab plus taxane: BALAST study」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル